CN102603724B - Method for purifying and refining dimethoxy taxane compound - Google Patents

Method for purifying and refining dimethoxy taxane compound Download PDF

Info

Publication number
CN102603724B
CN102603724B CN201210038631.3A CN201210038631A CN102603724B CN 102603724 B CN102603724 B CN 102603724B CN 201210038631 A CN201210038631 A CN 201210038631A CN 102603724 B CN102603724 B CN 102603724B
Authority
CN
China
Prior art keywords
dimethoxy
product
equivalent
ethyl acetate
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210038631.3A
Other languages
Chinese (zh)
Other versions
CN102603724A (en
Inventor
陈磊
郑伟
李隆
王琼
徐信保
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuxi Yew Pharmaceutical Co ltd
Original Assignee
JIANGSU HODO BIO-TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGSU HODO BIO-TECHNOLOGY Co Ltd filed Critical JIANGSU HODO BIO-TECHNOLOGY Co Ltd
Priority to CN201210038631.3A priority Critical patent/CN102603724B/en
Publication of CN102603724A publication Critical patent/CN102603724A/en
Application granted granted Critical
Publication of CN102603724B publication Critical patent/CN102603724B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a method for purifying and refining a dimethoxy taxane compound, in particular to the method for purifying and refining 3-tert-butoxycarbonyl-2-p-methoxyphenyl-4-phenyl-(2R,4S,5R)-1,3-oxazolidinyl-5-carboxylic acid-4alpha-acetoxyl-2alpha-benzoyloxy-5beta,20-epoxy-1beta-hydroxy-9-oxo-7beta,10beta-dimethoxy-11-taxadiene-13alpha ester. The method comprises the following steps: carrying out silica-gel column chromatography on a crude product; eluting the crude product by using petroleum ether/ethyl acetate; collecting the eluate; concentrating to obtain an initial product; allowing reaction between a compounding reagent with the initial product; washing; and refining to prepare the required product. The method is simple in operation and easy for industrial production; and byproducts cannot be generated in the reaction process, so that the reaction yield is increased and the product purity is improved.

Description

The method of dimethoxy bearing taxanes purification refine
Technical field
The present invention relates to a kind of method of dimethoxy bearing taxanes purification refine, be specifically related to a kind of 3-tertbutyloxycarbonyl-2-p-methoxyphenyl-4-phenyl-(2R, 4S, 5R)-1,3-oxazolidine-5-carboxylic acid 4 α-acetoxyl group-2 α-benzoyloxy-5 β, 20-epoxy-1 beta-hydroxy-9-oxygen-7 β, the process for purification refine of 10 β-dimethoxy-11-yew alkene-13 α ester.
Background technology
3-tertbutyloxycarbonyl-2-p-methoxyphenyl-4-phenyl-(2R, 4S, 5R)-1,3-oxazolidine-5-carboxylic acid 4 α-acetoxyl group-2 α-benzoyloxy-5 β, 20-epoxy-1 beta-hydroxy-9-oxygen-7 β, 10 β-dimethoxy-11-yew alkene-13 α ester is that compound (1) is an important taxane compounds, in the multiple antineoplastic taxane hydride compounds of preparation and bulk drug, all has application.A kind of method of preparing this compound is disclosed in patent CN 1179776A, in the method by dimethyl sulphide intermediate at Raney Ni, under the condition of hydrogen and ethanol, reaction obtains after the crude product of compound (1), directly passes through the product that silica gel column chromatography (dichloromethane/ethyl acetate is moving phase) obtains compound (1).But applicant finds this preparation method and can produce a large amount of byproducts of reaction, and by conventional column chromatography and mesohigh preparative column, be all difficult to the separated of realization response by product and compound (1), thereby cause obtaining the compound (1) of higher degree.
The reaction equation that patent CN 1179776A mentions is as follows:
Summary of the invention
The object of the invention is to overcome above-mentioned weak point, provide a kind of simple to operate, be easy to 3-tertbutyloxycarbonyl-2-p-methoxyphenyl-4-phenyl-(2R of suitability for industrialized production, 4S, 5R)-1,3-oxazolidine-5-carboxylic acid 4 α-acetoxyl group-2 α-benzoyloxy-5 β, 20-epoxy-1 beta-hydroxy-9-oxygen-7 β, the process for purification of 10 β-dimethoxy-11-yew alkene-13 α ester.
According to technical scheme provided by the invention, a kind of method of dimethoxy bearing taxanes purification refine, step is as follows:
(1) preparation of primary product: get 3-tertbutyloxycarbonyl-2-p-methoxyphenyl-4-phenyl-(2R, 4S, 5R)-1,3-oxazolidine-5-carboxylic acid 4 α-acetoxyl group-2 α-benzoyloxy-5 β, 20-epoxy-1 beta-hydroxy-9-oxygen-7 β, the thick product of 10 β-dimethoxy-11-yew alkene-13 α ester, carry out silica gel column chromatography, use sherwood oil: 1: 10~10: 1 pairs of thick products of ethyl acetate carry out wash-out, collect elutriant, the concentrated primary product that obtains;
(2) preparation of pending product: add following any one agent combination in primary product, in the quality of primary product: 1. diacetyl oxide, Cerous chloride heptahydrate and tetrahydrofuran (THF); 2. 2,2,2-trichlorine ethoxy carbonyl chloride, pyridine and methylene dichloride; 3. methyl-sulphoxide, diacetyl oxide and acetic acid;-80~100 ℃ of stirring reaction 1-96h, by in the frozen water of reaction solution impouring 15~20 equivalents, the organic solvent that adds again 10~20 equivalents, fully stir 30~60min, isolate organic phase, with the saturated common salt moisture of 3000mL, clean organic phase 1-3 time, then use anhydrous sodium sulfate drying, under 30~40 ℃ of decompression 2.1~2.7kPa, be concentrated into after dry and obtain pending product;
(3) refinement treatment: by the pending product silica gel column chromatography of step (2) gained, the mixed solvent that uses petrol ether/ethyl acetate to form carries out wash-out, collection contains 3-tertbutyloxycarbonyl-2-p-methoxyphenyl-4-phenyl-(2R, 4S, 5R)-1,3-oxazolidine-5-carboxylic acid 4 α-acetoxyl group-2 α-benzoyloxy-5 β, 20-epoxy-1 beta-hydroxy-9-oxygen-7 β, the elutriant of 10 β-dimethoxy-11-yew alkene-13 α ester, is concentrated into the product dimethoxy bearing taxanes after dry being refined under 30~40 ℃ of decompression 2.1~2.7kPa.
In step (2), add the amount of reagent as follows, in the quality of step (1) gained primary product: 1. diacetyl oxide 0.1~10 equivalent, Cerous chloride heptahydrate 0.1~10 equivalent and tetrahydrofuran (THF) 5~15 equivalents; 2. 2,2,2-trichlorine ethoxy carbonyl chloride 0.1~10 equivalent, pyridine 0.2~20 equivalent and methylene dichloride 5~15 equivalents; Or 3. methyl-sulphoxide 0.1~100 equivalent, diacetyl oxide 0.1~100 equivalent and acetic acid 0.1~100 equivalent.
Described silicagel column is 400~800 orders.
In step (2), temperature of reaction is room temperature, and the reaction times is 22~26h.
In step (2), organic solvent is ethyl acetate or methylene dichloride.
The eluent components adopting during described silica gel column chromatography and ratio thereof are sherwood oil: ethyl acetate is 100: 1~1: 100.
Tool of the present invention has the following advantages: the invention provides a kind of 3-tertbutyloxycarbonyl-2-p-methoxyphenyl-4-phenyl-(2R, 4S, 5R)-1,3-oxazolidine-5-carboxylic acid 4 α-acetoxyl group-2 α-benzoyloxy-5 β, 20-epoxy-1 beta-hydroxy-9-oxygen-7 β, the process for purification refine of 10 β-dimethoxy-11-yew alkene-13 α ester, it is simple to operate, be easy to suitability for industrialized production, in reaction process, can not produce by product, improved reaction yield and product purity.
Accompanying drawing explanation
Product nuclear magnetic resonance map prepared by Fig. 1 the present invention.
Embodiment
Embodiment 1
30.0 grams of the thick products of the resulting product of preparation method (purity is 73.8%) of the compound (1) according to proposing in patent CN 1179776A are being equipped with to chromatography column (20 centimetres of the internal diameters of 1.2 kilograms of 400-800 order silica gel, high 80 centimetres) in carry out separation, the mixed solvent that uses petrol ether/ethyl acetate to form carries out wash-out, the elutriant that collection contains compound (1), 40 ℃ of decompressions (2.7KPa) are concentrated into the dry 12.0 grams of crude products that obtain, and purity is 89.4%.
Above-mentioned crude product is dropped in tetrahydrofuran (THF) (120mL), add diacetyl oxide (1.2mL), Cerous chloride heptahydrate (0.94g), after room temperature reaction 24 hours, in impouring frozen water (500mL), add ethyl acetate (200mL), fully stir 30 minutes.Isolate organic phase, saturated common salt washing (1000mL * 3), anhydrous sodium sulfate drying, 40 ℃ of decompressions (2.7KPa) are concentrated into dry slightly product.
Above-mentioned concentrated thick product is being equipped with to chromatography column (20 centimetres of the internal diameters of 0.8 kilogram of 400-800 order silica gel, high 80 centimetres) in carry out separation, the mixed solvent that uses petrol ether/ethyl acetate to form 1: 10 carries out wash-out, the elutriant that collection contains compound (1), 40 ℃ of decompressions (2.7KPa) are concentrated into the dry 11.2 grams of refined products that obtain, and purity is 94.5%.
Embodiment 2
30.0 grams of the thick products of the resulting product of preparation method (purity is 73.8%) of the compound (1) according to proposing in patent CN 1179776A are being equipped with to chromatography column (20 centimetres of the internal diameters of 1.2 kilograms of 400-800 order silica gel, high 80 centimetres) in carry out separation, the mixed solvent that uses petrol ether/ethyl acetate to form carries out wash-out, the elutriant that collection contains compound (1), 40 ℃ of decompressions (2.7KPa) are concentrated into the dry 12.0 grams of crude products that obtain, and purity is 89.4%.
Above-mentioned crude product is dropped in methylene dichloride (60mL), add pyridine (1.0mL), at 0 ℃, drip 2,2,2-trichlorine ethoxy carbonyl chloride (0.87mL), drips and finishes, after room temperature reaction 24 hours, in impouring frozen water (500mL), add methylene dichloride (400mL), fully stir 30 minutes.Isolate organic phase, saturated common salt washing (1000mL * 3), anhydrous sodium sulfate drying, 40 ℃ of decompressions (2.7KPa) are concentrated into dry slightly product.
Above-mentioned concentrated thick product is being equipped with to chromatography column (20 centimetres of the internal diameters of 0.8 kilogram of 400-800 order silica gel, high 80 centimetres) in carry out separation, the mixed solvent that uses petrol ether/ethyl acetate to form at 1: 100 carries out wash-out, the elutriant that collection contains compound (1), 40 ℃ of decompressions (2.7KPa) are concentrated into the dry 11.2 grams of refined products that obtain, and purity is 93.6%.
Embodiment 3
30.0 grams of the thick products of the resulting product of preparation method (purity is 73.8%) of the compound (1) according to proposing in patent CN 1179776A are being equipped with to chromatography column (20 centimetres of the internal diameters of 1.2 kilograms of 400-800 order silica gel, high 80 centimetres) in carry out separation, the mixed solvent that uses petrol ether/ethyl acetate to form carries out wash-out, the elutriant that collection contains compound (1), 40 ℃ of decompressions (2.7KPa) are concentrated into the dry 12.0 grams of crude products that obtain, and purity is 89.4%.
Above-mentioned crude product is dropped in methyl-sulphoxide (24.0mL), add diacetyl oxide (16.0mL), acetic acid (1.0mL), after room temperature reaction 96 hours, in impouring frozen water (1000mL), add ethyl acetate (800mL), fully stir 30 minutes.Isolate organic phase, saturated sodium bicarbonate aqueous solution is washed (1000mL * 3), saturated common salt washing (1000mL * 3), and anhydrous sodium sulfate drying, 40 ℃ of decompressions (2.7KPa) are concentrated into dry slightly product.
Above-mentioned concentrated thick product is being equipped with to chromatography column (20 centimetres of the internal diameters of 0.8 kilogram of 400-800 order silica gel, high 80 centimetres) in carry out separation, the mixed solvent that uses petrol ether/ethyl acetate to form at 100: 1 carries out wash-out, the elutriant that collection contains compound (1), 40 ℃ of decompressions (2.7KPa) are concentrated into the dry 11.2 grams of refined products that obtain, and purity is 92.8%.
Get embodiment 3 products and carry out nucleus magnetic resonance.
Be illustrated in figure 1 product nuclear magnetic resonance spectrum 1h-NMR (400MHz:CDCl 3; Chemical shift δ ppm; Coupling constant J Hz)
1.03(s,9H);1.07(s,3H);1.19(s,3H);1.51(s,3H);1.68(s,3H);1.82(dd,J=15.9,1H);1.89(s,3H);2.09(m,2H);2.65(dd,J=15.9,1H);3.25(s,3H);3.39(s,3H);3.83(d,J=7,1H);3.83(s,3H);4.12(d,J=8,1H);4.26(d,J=8,1H);4.55(d,J=8,1H);4.70(s,1H);4.88(d,J=12,1H);5.40(bs,1H);5.60(d,J=12,1H);6.12(t,J=10,1H);6.39(bs,1H);6.91(d,J=10,2H);7.38-7.64(mt,10H);8.03(d,J=10,2H)

Claims (5)

1. a method for dimethoxy bearing taxanes purification refine, is characterized in that step is as follows:
(1) preparation of primary product: get 3-tertbutyloxycarbonyl-2-p-methoxyphenyl-4-phenyl-(2 r, 4 s, 5 r)-1,3-oxazolidine-5-carboxylic acid 4 α-acetoxyl group-2 α-benzoyloxy-5 β, 20-epoxy-1 beta-hydroxy-9-oxygen-7 β, the thick product of 10 β-dimethoxy-11-yew alkene-13 α ester, carry out silica gel column chromatography, use sherwood oil and eluent ethyl acetate liquid to carry out wash-out to thick product, collect elutriant, the concentrated primary product that obtains;
(2) preparation of pending product: add following any one agent combination in primary product, in the quality of primary product: 1. diacetyl oxide, Cerous chloride heptahydrate and tetrahydrofuran (THF); 2. 2,2,2-trichlorine ethoxy carbonyl chloride, pyridine and methylene dichloride; 3. methyl-sulphoxide, diacetyl oxide and acetic acid;-80 ~ 100 ℃ of stirring reaction 1-96h, by in the frozen water of reaction solution impouring 15 ~ 20 equivalents, the organic solvent that adds again 10 ~ 20 equivalents, fully stir 30 ~ 60min, isolate organic phase, with the saturated common salt moisture of 3000mL, clean organic phase 1-3 time, then use anhydrous sodium sulfate drying, under 30 ~ 40 ℃ of decompression 2.1 ~ 2.7kPa, be concentrated into after dry and obtain pending product;
(3) refinement treatment: by the pending product silica gel column chromatography of step (2) gained, the mixed solvent that uses petrol ether/ethyl acetate to form carries out wash-out, collects and contains 3-tertbutyloxycarbonyl-2-p-methoxyphenyl-4-phenyl-(2 r, 4 s, 5 r)-1,3-oxazolidine-5-carboxylic acid 4 α-acetoxyl group-2 α-benzoyloxy-5 β, 20-epoxy-1 beta-hydroxy-9-oxygen-7 β, the elutriant of 10 β-dimethoxy-11-yew alkene-13 α ester, is concentrated into the product dimethoxy bearing taxanes after dry being refined under 30 ~ 40 ℃ of decompression 2.1 ~ 2.7kPa;
In step (2), add the amount of reagent as follows, in the quality of step (1) gained primary product: 1. diacetyl oxide 0.1 ~ 10 equivalent, Cerous chloride heptahydrate 0.1 ~ 10 equivalent and tetrahydrofuran (THF) 5 ~ 15 equivalents; 2. 2,2,2-trichlorine ethoxy carbonyl chloride 0.1 ~ 10 equivalent, pyridine 0.2 ~ 20 equivalent and methylene dichloride 5 ~ 15 equivalents; 3. methyl-sulphoxide 0.1 ~ 100 equivalent, diacetyl oxide 0.1 ~ 100 equivalent and acetic acid 0.1 ~ 100 equivalent.
2. the method for dimethoxy bearing taxanes purification refine according to claim 1, is characterized in that: described silicagel column is 400 ~ 800 orders.
3. the method for dimethoxy bearing taxanes purification refine according to claim 1, is characterized in that: in step (2), temperature of reaction is room temperature, and the reaction times is 22 ~ 26h.
4. the method for dimethoxy bearing taxanes purification refine according to claim 1, is characterized in that: in step (2), organic solvent is ethyl acetate or methylene dichloride.
5. the method for dimethoxy bearing taxanes purification refine according to claim 1, is characterized in that: the eluent components adopting during described silica gel column chromatography and ratio thereof are sherwood oil: ethyl acetate is 100:1 ~ 1:100.
CN201210038631.3A 2011-10-20 2012-02-20 Method for purifying and refining dimethoxy taxane compound Active CN102603724B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210038631.3A CN102603724B (en) 2011-10-20 2012-02-20 Method for purifying and refining dimethoxy taxane compound

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201110322882.X 2011-10-20
CN201110322882 2011-10-20
CN201210038631.3A CN102603724B (en) 2011-10-20 2012-02-20 Method for purifying and refining dimethoxy taxane compound

Publications (2)

Publication Number Publication Date
CN102603724A CN102603724A (en) 2012-07-25
CN102603724B true CN102603724B (en) 2014-02-26

Family

ID=46521554

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210038631.3A Active CN102603724B (en) 2011-10-20 2012-02-20 Method for purifying and refining dimethoxy taxane compound

Country Status (1)

Country Link
CN (1) CN102603724B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1179776A (en) * 1995-03-27 1998-04-22 罗纳-布朗克罗莱尔股份有限公司 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
CN1944435A (en) * 2006-10-19 2007-04-11 上海大学 New 4-substituent-1-dehydroxy baccatin VI derivative and its preparing method
CN102093315A (en) * 2010-12-23 2011-06-15 上海大学 C7 and C10 modified 1-dehydroxyl taxol analogue and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1179776A (en) * 1995-03-27 1998-04-22 罗纳-布朗克罗莱尔股份有限公司 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
CN1944435A (en) * 2006-10-19 2007-04-11 上海大学 New 4-substituent-1-dehydroxy baccatin VI derivative and its preparing method
CN102093315A (en) * 2010-12-23 2011-06-15 上海大学 C7 and C10 modified 1-dehydroxyl taxol analogue and preparation method thereof

Also Published As

Publication number Publication date
CN102603724A (en) 2012-07-25

Similar Documents

Publication Publication Date Title
CN111944006A (en) New 7-keto-6 beta-alkyl cholanic acid derivative in preparation of obeticholic acid and application thereof in medical field
CN102603724B (en) Method for purifying and refining dimethoxy taxane compound
CN106256833B (en) The method for preparing 3,7- bis- (trimethyl silicon substrate oxygroup) -5 β of -6- alkene-cholane -24- acid methyl esters
EP2872477B1 (en) Process for the preparation of ingenol-3-angelate from 20-deoxy-ingenol
CN103402973B (en) Compound and production method thereof, and for the production of the method for Ro 64-0796/002
CN107641080B (en) A kind of dihydronaphthalene ketones derivant and preparation method thereof containing spirane structure
CN106117222A (en) Benzophenanthrene dodecyloxy bridging isobutyltrimethylmethane. phenyl porphyrin binary compound discotic mesogenic material synthesis method
CN108314641B (en) Preparation method of natural product Norpsilocin
Satake et al. Scalable synthesis of a new dihydroxylated intermediate for tetrodotoxin and its analogues
CN106117220A (en) The synthetic method of benzophenanthrene dodecyloxy bridging isobutyltrimethylmethane. phenyl porphyrin metal Zn coordination compound
CN106905358B (en) Preparation of vitamin D3Process for preparing analogue intermediates
CN108299297A (en) A kind of novel 6- alkyl phenanthridines and derivative and preparation method thereof
CN105017268A (en) 2-tertbutyloxycarbonyl-7-carbonyl-5-O-2-azaspiro(3.4)octane synthesis method
Setterholm et al. Sequential exo-mode oxacyclizations for the synthesis of the CD substructure of brevenal
CN106905308B (en) A kind of thia cup [4] arene derivatives and preparation method thereof
CN105884706A (en) Cetilistat efficient synthesizing method
Betz et al. Preparation of Highly Hindered Polyenes with tert‐Butyl Groups in Internal Positions
CN107200770B (en) In the synthesis of special plast ketone eposide isomers efficiently separate and circulation utilization method
CN107628919A (en) A kind of method of synthesis β halogen formate esters compounds
CN109970643A (en) A kind of green synthesis method of the Activities of Tetrahydroacridine Derivatives under the promotion of iodine anion
CN106349073B (en) A kind of synthetic method of phenacylidene malonic acid ester type compound
CN109486866A (en) The method that biocatalysis prepares (S) -4- decyl alcohol
CN103044448B (en) A kind of synthetic method of Tazobactam Sodium
CN108840881A (en) A kind of tetra- substituted benzene of 1,2,3,5- and its synthetic method of the silicon substrate containing 3-
CN102260236A (en) Preparation method of coumarin compounds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: 214199 Xishan City, Jiangsu Province, Donggang Town, Hong Kong under the red bean Group Co., Ltd.

Applicant after: JIANGSU YEW BIOTECHNOLOGY CO.,LTD.

Address before: 214199 Xishan City, Jiangsu Province, Donggang Town, Hong Kong under the red bean Group Co., Ltd.

Applicant before: JIANGSU YEW BIOTECHNOLOGY Co.,Ltd.

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: JIANGSU YEW BIOTECHNOLOGY CO., LTD. TO: JIANGSU YEW BIOTECHNOLOGY CO., LTD.

C14 Grant of patent or utility model
GR01 Patent grant
CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: 214199 Jiangsu Wuxi Xishan District Donggang Town Hong Kong Red Group Co., Ltd.

Patentee after: JIANGSU YEW HEALTH TECHNOLOGY CO.,LTD.

Address before: 214199 Jiangsu Wuxi Xishan District Donggang Town Hong Kong Red Group Co., Ltd.

Patentee before: JIANGSU YEW BIOTECHNOLOGY CO.,LTD.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20220819

Address after: 214199 No. 111, Qinxin Road, Donggang Town, Xishan District, Wuxi City, Jiangsu Province

Patentee after: Wuxi yew Pharmaceutical Co.,Ltd.

Address before: 214199 Jiangsu Wuxi Xishan District Donggang Town Hong Kong Red Group Co., Ltd.

Patentee before: JIANGSU YEW HEALTH TECHNOLOGY CO.,LTD.